Effects of mixed polyethyleneglycol modification on fixed aqueous layer thickness and antitumor activity of doxorubicin containing liposome

被引:115
作者
Sadzuka, Y [1 ]
Nakade, A [1 ]
Hirama, R [1 ]
Miyagishima, A [1 ]
Nozawa, Y [1 ]
Hirota, S [1 ]
Sonobe, T [1 ]
机构
[1] Univ Shizuoka, Sch Pharmaceut Sci, Yada, Shizuoka 4228526, Japan
关键词
polyethyleneglycol; stealth liposome; doxorubicin; the fixed aqueous layer thickness (FALT); passive targeting;
D O I
10.1016/S0378-5173(02)00075-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Polyethyleneglycol (PEG) has often been used for the modification of liposomes, but it is difficult to insert PEG on the surface of liposomes, and the effects of modification are not marked enough. In this study, we examined the fixed aqueous layer thickness (FALT) of single or mixed PEG (molecular weight, 340, 500, 900, 2000)-modified doxorubicin (DOX) liposomes, and physical character and biological properties of these liposomes. On single PEG-modification, as the PEG-molecular weight increased, FALT also increased, but the ratio of the increase was reduced. While on modification by a mixture of PEG2000 and PEG with a short polyoxyethylene chain (PEG340 or PEG500),. FALT increased compared with the single PEG2000-modified value. Moreover, when liposomes were modified by mixture of PEG2000 and PEG500, we recognized the most suitable mixed rate (PEG2000, 500 = 2: 1), showed the maximum FALT. On the other hand, in vivo, as increase of FALT, DOX concentrations increased in the plasma and in the tumor, decreased in the liver. Furthermore, liposomes with remarkable increase of FALT showed enhancement of antitumor activity. As a result, the connection among increase of FALT and improvement of circulation in blood, the involvement of antitumor activity of DOX of these liposomes was suggested. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:171 / 180
页数:10
相关论文
共 31 条
[1]  
[Anonymous], 1985, INTERMOLECULAR SURFA
[2]  
BALAZSOVITS JAE, 1989, CANCER CHEMOTH PHARM, V23, P81
[3]   DIFFUSION OF UNIVALENT IONS ACROSS LAMELLAE OF SWOLLEN PHOSPHOLIPIDS [J].
BANGHAM, AD ;
STANDISH, MM ;
WATKINS, JC .
JOURNAL OF MOLECULAR BIOLOGY, 1965, 13 (01) :238-+
[4]  
BENJAMIN RS, 1977, CANCER RES, V37, P1416
[5]  
BERESTEIN GL, 1984, CANCER RES, V44, P375
[6]   ADRIAMYCIN - NEW ANTICANCER DRUG WITH SIGNIFICANT CLINICAL ACTIVITY [J].
BLUM, RH ;
CARTER, SK .
ANNALS OF INTERNAL MEDICINE, 1974, 80 (02) :249-259
[7]   ANALYSIS OF ADRIAMYCIN AND ADRIAMYCINOL IN MICRO VOLUMES OF RAT PLASMA [J].
BOTS, AMB ;
VANOORT, WJ ;
NOORDHOEK, J ;
VANDIJK, A ;
KLEIN, SW ;
VANHOESEL, QGCM .
JOURNAL OF CHROMATOGRAPHY, 1983, 272 (02) :421-427
[8]   Polyethylene glycol-liposomal doxorubicin - A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of AIDS-related Kaposi's sarcoma [J].
Coukell, AJ ;
Spencer, CM .
DRUGS, 1997, 53 (03) :520-538
[9]   COMPARATIVE PHARMACOKINETIC STUDY OF ADRIAMYCIN AND 4'EPI-ADRIAMYCIN AFTER THEIR SIMULTANEOUS INTRAVENOUS ADMINISTRATION [J].
EKSBORG, S ;
STENDAHL, U ;
LONROTH, U .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 30 (05) :629-631
[10]   USE OF ANIONIC LIPOSOMES FOR THE REDUCTION OF CHRONIC DOXORUBICIN-INDUCED CARDIOTOXICITY [J].
FORSSEN, EA ;
TOKES, ZA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (03) :1873-1877